Lantern Pharma
Price & Volume
Stats
See more52W Range | $1.11-$5.74 |
Market Cap | $21.8M |
Shares Short | 312,900 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$1.72 |
News
See moreYahoo Finance • 20 days ago
New to The Street Announces Broadcast of Show #739 on Bloomberg Television Across the U.S. at 6:30 PM EST
Yahoo Finance • 2 months ago
Lantern Pharma (LTRN) Advances Oncology AI and Gains Orphan Drug Recognition
Yahoo Finance • 7 months ago
Lantern Pharma Says Phase 1a Study Of LP-184 Met All Primary Endpoints In Advanced Solid Tumors
About
CEO | Mr. Panna Sharma |
CFO | Mr. David R. Margrave |
Address | 1920 McKinney Avenue, Dallas, TX, United States, 75201 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 24 |
